Regional Analysis

Global Sepsis Diagnostics Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global sepsis diagnostics market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global sepsis diagnostics market is expected to witness significant growth in the coming years, driven by the increasing funding opportunities for research and development activities by market players in the North America region. For instance, on June 8, 2021, CARB-X, a U.S based biotechnology company, raised funds up to US$ 578,000 to develop new fiber optic technology to diagnose sepsis or the risk of sepsis. Accelerate would be eligible for up to US$ 2.1 million in additional funds from CARB-X if the project meets certain milestones, subject to available funds. A rapid test is especially important for sepsis treatment, where every hour of delay in appropriate treatment reduces the chance of survival.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa